A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254

Anti-B4-blocked ricin (anti-B4-bR) is a potent immunotoxin directed against the CD 19 antigen. Previous phase I and II studies suggested a possible role for anti-B4-bR as consolidation after high-dose chemotherapy and autologous stem cell transplant. Cancer and Leukemia Group B (CALGB) 9254 is a pha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Furman, Richard R., Grossbard, Michael L., Johnson, Jeffrey L., Pecora, Andrew L., Cassileth, Peter A., Jung, Sin-Ho, Peterson, Bruce A., Nadler, Lee M., Freedman, Arnold, Bayer, Ruthee-Lu, Bartlett, Nancy L., Hurd, David D., Cheson, Bruce D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3682835/
https://ncbi.nlm.nih.gov/pubmed/21275630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2010.543714
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados